Clinical and Echocardiographic Variables Fail to Predict Response to Dual-Chamber Pacing for Hypertrophic Cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 21, Issue 7, 2008, Pages 796-800

  Binder, Josepha ^a   Ommen, Steve R ^b   Sorajja, Paul ^b   Nishimura, Rick A ^b   Tajik, A Jamil ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Dual chamber pacing; Hypertrophic cardiomyopathy

Indexed keywords

ADULT; AGED; ARTICLE; DUAL CHAMBER PACING THERAPY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PATIENT IDENTIFICATION; PREDICTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD FLOW VELOCITY; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 45849097648     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2007.11.014     Document Type: Article

References (19)

1. Maron B.J., Dearani J.A., Ommen S.R., et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2005) 2044-2053
2. Hess O.M., and Sigwart U. New treatment strategies for hypertrophic cardiomyopathy: alcohol ablation of the septum; the new gold standard?. J Am Coll Cardiol 44 (2005) 2054-2055
3. Fananapazir L., Cannon III R.O., Tripodi D., and Panza J.A. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 85 (1992) 2149-2161
4. Fananapazir L., Epstein N., Curiel R., Panze J., Tripodi D., and McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90 (1994) 2731-2742
5. Kappenberger L. Pacing for obstructive hypertrophic cardiomyopathy. Br Heart J 73 (1995) 107
6. Betocchi S., Losi M.A., Piscione F., et al. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol 77 (1996) 498-502
7. Nishimura R.A., Hayes D.L., Ilstrup D.M., Holmes Jr. D.R., and Tajik A.J. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 27 (1996) 421-430
8. Slade A.K., Sadoul N., Shapiro L., et al. DDD pacing in hypertrophic cardiomyopathy: a multicenter clinical experience. Heart 75 (1996) 44-49
9. Nishimura R.A., Trusty J.M., Hayes D.L., et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 29 (1997) 435-441
10. Maron B.J., Nishimura R.A., McKenna W.J., Rakowski H., Josephson M.E., and Kieval R.S. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, crossover study (M-PATHY). Circulation 99 (1999) 2927-2933
11. Ommen S.R., Nishimura R.A., Squires R.W., Schaff H.V., Danielson G.K., and Tajik A.J. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertropic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol 34 (1999) 191-196
12. Erwin III J.P., Nishimura R.A., Lloyd M.A., and Tajik A.J. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000. Mayo Clin Proc 75 (2000) 173-180
13. Meisel E., Rauwolf T., Burghardt M., and Kappenberger L. Pacemaker therapy of hypertrophic obstructive cardiomyopathy: PIC (pacing in cardiomyopathy) study group. Herz 25 (2000) 461-466
14. Jiang L., Levine R.A., King M.E., and Weyman A.E. An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations. Am Heart J 113 (1987) 633-644
15. Cape E.G., Simons D., Jimoh A., Weyman A.E., Yoganathan A.P., and Levine R.A. Chordal geometry determines the shape and extent of systolic anterior mitral motion: in vitro studies. J Am Coll Cardiol 13 (1989) 1438-1448
16. Sherrid M.V., Chu C.K., Delia E., Mogtader A., and Dwyer Jr. E.M. An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 22 (1993) 816-825
17. Sherrid M.V., Gunsburg D.Z., Moldenhauer S., and Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 36 (2000) 1344-1354
18. Talreja D.R., Nishimura R.A., Edwards W.D., et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 44 (2004) 2329-2332
19. Qin J.X., Shiota T., Lever H.M., et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93 (2004) 171-175